NEW YORK (GenomeWeb News) – A variant in a major histocompatibility complex, or MHC, region on chromosome 6 appears to hold promise for predicting which individuals will develop graft versus host disease (GVHD) after receiving blood stem cell transplants from non-relatives, according to a new study.